Journal article
PP93 HTA Role In CoreHEM, A Multi-Stakeholder Core Outcome Set Project
Abstract
Introduction:
Hemophilia gene therapy trials demonstrate a “cure” could be achievable, thereby changing disease management. CoreHEM aims to develop multi-stakeholder consensus around a clearly defined, core outcome set (COS) - a minimum set of outcomes that should be measured and reported in all clinical trials of a specific condition - that will demonstrate and allow differentiation of the effectiveness and value of gene …
Authors
Clearfield E; Skinner M; Iorio A; Tunis S; Al Naber J; Messner D
Journal
International Journal of Technology Assessment in Health Care, Vol. 34, No. S1, pp. 100–101
Publisher
Cambridge University Press (CUP)
Publication Date
2018
DOI
10.1017/s0266462318002386
ISSN
0266-4623